Financial News
Articles published by MaxCyte, Inc
MaxCyte Announces Retirement of Board Member Art Mandell
Today 2:00 EST
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics
November 13, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance
November 06, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte to Participate in Two Upcoming Investor Conferences
October 31, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
October 10, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
September 05, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance
August 06, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 12, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
January 08, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director
January 02, 2024
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
December 11, 2023
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
November 16, 2023
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
November 08, 2023
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte to Participate in Two Upcoming Investor Conferences
November 06, 2023
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
October 04, 2023
From MaxCyte, Inc
Via GlobeNewswire
Tickers
MXCT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.